In a significant stride towards fortifying indigenous manufacturing capabilities and fostering innovation in the pharmaceutical sector, the Technology Development Board (TDB) has entered into an agreement with Alchem Synthon, Mumbai. The board will provide a loan assistance of Rs 8.6 crore out of the total project cost of Rs 19.01 crore for the development and commercialisation of advanced pharmaceutical intermediates, fine & specialty chemicals.

The project aims to establish a state-of-the-art manufacturing facility dedicated to large-scale production of Key Starting Materials (KSMs) and Advanced Intermediates, pivotal for Active Pharmaceutical Ingredients (APIs) that comply with stringent quality standards. Additionally, the facility will manufacture Specialty and Fine Chemicals tailored to various applications across industries such as Polymer and Water Treatment facilities.

Upon completion, the new manufacturing facility will increase production capacity, targeting an output of 12,000 Kg per month compared to the existing capacity of 1,000 Kg per month. Moreover, the facility will prioritize the synthesis of new intermediates and KSMs, catering to the needs of bulk drug/agrochemical industries that currently rely on imports for these critical chemicals.